Growing Chronic Diseases and Lifestyle-Related Disorders
The growing prevalence of chronic diseases and lifestyle-related disorders is one of the major factors for the growth of CTMS market. Globally, chronic diseases kill more than 38 million people each year. It is primarily related to cardiovascular diseases, cancer, respiratory diseases, and diabetes. Consequently, this demands more new drugs, devices, and procedures to be developed and reach the market. Thus, increasing the demand for a large number of clinical trials in collaboration with universities and private companies in multiple regions. The surging demand for CTMS for proper management of clinical trials is driving the market.
Other factors, such as a rise in the outsourcing of the clinical trials and implementation by contract research organization (CRO) and increasing number of hospital chains synchronizing the hospital information system (HIS) with CTMS are driving the market.
Concerns Related to Data Security
The confidentiality of data related to a company’s device in a clinical trial or a patient’s information in healthcare is required both online, as well as, offline. With technological advancement, the risk of privacy and security of the records also increases, which is one of the major hindrances to this market. The organizations are hit by the lack of transparency affecting their overall quality and cost, which affects the patients. Other factors such as high cost associated with CTMS and lack of qualified and skilled labor to handle CTMS also hamper the growth of this market.
North America to Dominate the Market
North America is expected to dominate this market in the forecast period due to favorable government initiatives, including support from government bodies such as NCI, FDA, and NIH. Moreover, raising awareness among people regarding diseases increases their participation in clinical trials. Asia-Pacific is also expected to grow tremendously during the forecast period owing to factors, such as huge, diverse patient pool, outsourcing of clinical trials to CROs, and rising healthcare facilities in the region.
Key Developments in the Market
- January 2018: ERT Clinical showcased Voice Assistant Data Capture Solution, which improved the patient data management in clinical trials through simplified patient data collection.
- November 2017: Bioclinica launched Bioclinica Clinical Adjudication enabling the independent adjudication of clinical events.
Reasons to Purchase the Report
- A look at the current and future of the global clinical trial management system market in the developed and emerging regions.
- Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
- Identify the segment that is expected to dominate the market.
- Identify the regions that are expected to witness the fastest growth during the forecast period.
- Identify the latest developments, market shares, and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet (in Excel).
This report can be customized to meet your requirements.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1.1 Rising Incidences of Chronic Diseases and Lifestyle-Related Disorders
6.1.2 Rise in Outsourcing of Clinical Trials and Implementation by Contract Research Organizations
6.1.3 Synchronization of Hospital Information System (HIS) with CTMS
6.2.1 Data Security Issues
6.2.2 High Cost Associated with CTMS
6.2.3 Lack of Qualified and Skilled Labor to Handle CTMS
6.4 Key Challenges
7. Market Segmentation
7.1 By Delivery Mode
7.1.1 Web-based Clinical Trial Management System
7.1.2 On-premise Clinical Trial Management System
7.1.3 Cloud-based Clinical Trial Management System
7.2 By Components
7.3 By End User
7.3.2 Clinical Research Organization
7.3.3 Healthcare Providers
7.4 By Type of System
7.4.1 Site-based Clinical Trial Management System
7.4.2 Licensed Enterprise-based Clinical Trial Management System
7.5 By Geography
7.5.1 North America
220.127.116.11 United States
18.104.22.168 Rest of North America
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
7.5.4 Middle East & Africa
220.127.116.11 South Africa
18.104.22.168 Rest of the Middle East & Africa
7.5.5 South America
22.214.171.124 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.2 Bio-Optronics, Inc.
9.3 DATATRAK International, Inc.
9.4 ERT Clinical
9.5 IBM Watson Health
9.6 Medidata Solutions, Inc.
9.7 MedNet Solutions, Inc.
9.8 Oracle Corporation
9.9 Parexel International Corporation
9.10 Sparta Systems, Inc.
9.11 List not Exhaustive
10. Future of the Market
- Bio-Optronics Inc.
- Datatrak International Inc.
- Ert Clinical
- Ibm Watson Health
- Medidata Solutions Inc.
- Mednet Solutions Inc.
- Oracle Corporation
- Parexel International Corporation
- Sparta Systems Inc.